Japanese scientists explore pluripotency

May 23, 2007

Japanese scientists have discovered how pluripotency -- the ability of stem cells to differentiate into other cell types -- is regulated.

Understanding how stem cells maintain pluripotent has involved the characterization of a multitude of transcription factors -- the proteins that determine whether a specific gene is expressed or not.

Pluripotency in embryonic stem cells was thought to be controlled primarily by the transcription factors Oct3/4 and Sox2, as these proteins were believed to activate Oct-Sox enhancers, which are regulatory regions that determine expression of pluripotent stem cell-specific genes.

Shinji Masui and colleagues at the International Medical Center of Japan used mutant mice lacking the Sox2 gene to show although Sox2 is needed for stem cell pluripotency, it is not required for the enhancers to function and, in fact, governs the expression of Oct3/4.

They also demonstrated the regulation is indirect, as Sox2 controls the expression of a number of transcription factors that in turn regulate Oct3/4 expression.

The researchers said their findings represent another small step toward a complete understanding of stem cell biology.

The research appears in the June issue of Nature Cell Biology.

Copyright 2007 by United Press International

Explore further: Targeting bladder cancer's Achilles heel: stem cells

Related Stories

Targeting bladder cancer's Achilles heel: stem cells

January 24, 2018

Two different proteins work separately as well as synergistically to feed a small pool of stem cells that help bladder cancer resist chemotherapy, research led by a Johns Hopkins Kimmel Cancer Center scientist suggests. The ...

New method for suppressing lung cancer oncogene

November 30, 2017

Researchers at Okayama University describe in Oncotarget an approach for suppressing the expression of the SOX2 protein, an oncogene associated with both lung and esophageal cancer. The procedure, based on the targeted delivery ...

Reprogrammed adult cells treat sickle-cell anemia in mice

December 6, 2007

Mice with a human sickle-cell anemia disease trait have been treated successfully in a process that begins by directly reprogramming their own cells to an embryonic-stem-cell-like state, without the use of eggs. This is the ...

Recommended for you

Reinventing the inductor

February 21, 2018

A basic building block of modern technology, inductors are everywhere: cellphones, laptops, radios, televisions, cars. And surprisingly, they are essentially the same today as in 1831, when they were first created by English ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.